LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,836 pages found matching %3Cscript%3Ealert%28%27What_Security%3F%27%29%3C%2Fscript%3E- Big Pharma Implant For-Profit Industry Not Deserving of Preemption Protection Part II
Jul-10-07 Washington, DC: All the major medical device makers are using the preemption argument against patients who were implanted with defective devices, but Minneapolis-based Medtronic is a regular pen-pal with the Justices at the U.S. Supreme Court. The Court ruled against the company on preemption in Medtronic v Lohr, 518 US 470 (1996), a case where a pace... - If Paxil doesn't Kill you with Guilt, Nothing Will
Jul-9-07 Toledo, OH Kristie Crayne started taking Paxil in 2000 and stayed on it during her pregnancy. Her daughter Megan was born in 2001. "I met other Moms' in the hospital who had also taken Paxil," says Crayne. "None of us knew Paxil caused birth defects. When you are sitting together in NICU you talk about how you are coping with a sick baby. 'I love that pi... - Big Pharma Implant For-Profit Industry Not Deserving of Preemption Protection Part I
Jul-9-07 Washington, DC: In addition to the question of how many soldiers will be dead or injured by the time self-proclaimed "war President" George Bush leaves office, Americans need to ask themselves how many citizens will be dead or injured as a result of an FDA controlled by the industry most credited with funding his move to the White House. Last year, the... - Johnson & Johnson Litigation Stories: Panacryl Sutures and the Duragesic Patch Part II
Jul-4-07 West Palm Beach, FL What do Panacryl sutures and the Duragesic patch have in common? Simply this: Both Johnson & Johnson products have both proven defective in an alarming number of cases, and both have caused untold misery and death. A defective Duragesic patch, a J&J pain relief patch containing a drug said to be more powerful than morphine, brough... - Johnson & Johnson litigation stories: Panacryl Sutures and the Duragesic Patch - Part I
Jul-2-07 West Palm Beach, FL Johnson & Johnson made the news June 20 after a West Palm Beach federal court jury awarded $5.5 million to the family of a young man who died while wearing a Duragesic pain relief patch. The Duragesic patch joins J&J's Panacryl suture as a newsmaker. Both products have hung J&J out to dry in court -- and both have left a trail of vict... - Panacryl Sutures: Another suture experiment brought to you by Ethicon
Jun-26-07 Pittsburgh, PA Ethicon Inc. has much to answer for. It is facing an undisclosed number of lawsuits from patients who have suffered or died because of alleged suture failure, the most recent wave of lawsuits relating to the absorbable Panacryl suture . Now a Pennsylvania jury has awarded $15 million damages to a victim's family because another Ethicon s... - Hotels Face Lawsuits Over Billing Practices
Jun-25-07 Orlando, FL: Customers are expected to pay an estimated $1.75 billion this year in "automatic" hotel fees and surcharges, including the "safe warranty fee." However, some of these hotel billing practices are illegal and lawsuits are now being filed challenging hotels for not disclosing their automatic fees until guests check out. Hotels are finding... - Intergel Scandal: A "Dangerous Precedent" at FDA?
Jun-24-07 Washington, DC In the wake of the Gynecare Intergel recall, many critics are questioning why the Food and Drug Administration (FDA) ever approved Intergel for medical use. Could it be, as some suggest, that the FDA is playing politics to its drug-company funders? Intergel: Initially "Not Approvable" Initially (2000) the FDA rejected Intergel as "no... - AMO Recall Not Soon Enough
Jun-22-07 Virginia Beach, VA "About one year ago I ordered contact lenses from Sam's Club and they gave me two "action pack" bottles of AMO Complete MoisturePlus Multi-Purpose Solution , "says Carey Jones. "If I knew about the AMO recall sooner, I may not have cornea damage." "I used the AMO solution right up until I heard on the news that it had been recalled,"... - California Overtime and Exemption: LawyersandSettlements.com asks an Expert
Jun-22-07 Washington, DC Lawyer Harvey Shulman has represented employers in several Department of Labor overtime investigations and class action litigations. In this interview with LawyersandSettlements, he explains California overtime versus overtime in other states, and whether or not an IT employee is exempt from overtime. "Let me start by mentioning my back... - Warning to Avandia Patients in Canada
Jun-22-07 Ottawa, ON Avandia Canada patients have been warned to speak with their doctors after a study published in the New England Journal of Medicine found a link between the risk of heart-related problems and Avandia. The study, published last month, combined the results of 42 clinical trials and found that Avandia increased the risk of heart attack by 43... - Glaxo now faces Lawsuit by Shareholders over Avandia Problems
Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of... - Lawmakers Go After Thugs at FDA Over Avandia
Jun-11-07 Washington, DC: In one of the latest developments in the Avandia diabetes drug saga, on June 7, 2007, a bipartisan group of powerful lawmakers sent a letter to FDA asking Commissioner Andrew von Eschenbach for an explanation of the agency's policy on conflicts of interest regarding hiring employees directly from drug companies regulated by the FDA. At... - Giant Law Firm loses California Labor Code case with Paralegal
Jun-5-07 Los Angeles, CA One of the largest law firms in the world has been brought to its knees by a woman who used to work for them as a paralegal. The international law firm of O'Melveny & Myers LLP, based in Los Angeles, has 13 offices worldwide and more than 1,000 lawyers in its employ. It has been around since 1885, and has had many notable partners throu... - High Anxiety over Avandia Report
May-30-07 Washington, DC Even the United States Senate is getting involved in the worried reaction to the report published last Monday claiming the popular diabetes drug Avandia raises the risk and severity of heart attacks. On May 21 the New England Journal of Medicine reported that an analysis of 42 separate studies on the drug concluded that Avandia rais... - Lawmakers Want to End Big Pharma Recruitment Schemes - Part 2
May-30-07 Washington, DC: The whole idea of mining for psychiatric drug customers by screening all Americans for mental health disorders came to fruition as the result of the campaign contributions by the pharmaceutical industry, which in large part helped George W Bush take up residence in the White House. To repay his enormous debt to the industry, on April 29,... - Lawmakers Want to End Big Pharma Recruitment Schemes - Part 1
May-29-07 Washington, DC: Federal lawmakers are stepping up the pace to put a stop to the pharmaceutical industry's customer recruitment schemes used to boost the sale of psychiatric drugs by tugging at heartstrings in promoting mental health screening programs as suicide prevention tools. On May 18, 2007, US House of Representative Ron Paul (R-Texas), a physicia... - Feds Investigate Profits From Off-Label Stent Procedures - Part II
May-25-07 Washington, DC: In addition to the federal investigations into the off-label marketing of drug eluting stents by Boston Scientific and Johnson & Johnson, on May 10, 2007, Rep Maurice Hinchey (D-NY), who serves on the House Appropriations Subcommittee, announced the introduction of the FDA reform bill which addresses the issue of doctors using product... - Fen-Phen Lawsuits: Shortness of Breath Could Signal PPH
May-25-07 Philadelphia, PA Lawsuits are still being filed against the maker of fen-phen, a popular diet drug combination that resulted in serious complications for many of the people who took it, including PPH. Primary pulmonary hypertension (PPH) and heart valve damage are two such complications. Many people who take medications do not think that they will... - Avandia Concerns Known Since 2000
May-24-07 Chapel Hill, NC The diabetes drug Avandia , which has been in the news this week following a report in the New England Journal of Medicine (NEJM) over concerns of a link to heart problems, continues to percolate throughout the prescription drug world - and telling information, lurking beneath the surface almost since the drug fist came onto the market, is...